Whitehawk Therapeutics, Inc.
WHWK
$4.27
-$0.13-2.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -79.83M | -115.81M | -20.60M | -15.62M | -10.42M |
| Total Depreciation and Amortization | 8.00K | 23.00K | 79.00K | 125.00K | 167.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.74M | 8.67M | -78.85M | -78.66M | -78.49M |
| Change in Net Operating Assets | 3.73M | -664.00K | 1.93M | -1.10M | -6.82M |
| Cash from Operations | -69.35M | -107.78M | -97.43M | -95.25M | -95.56M |
| Capital Expenditure | 0.00 | -1.00K | -552.00K | -738.00K | -926.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -70.00K | -70.00K | 101.29M | 101.29M | 101.36M |
| Other Investing Activities | -72.15M | -84.11M | -88.84M | -92.37M | 4.46M |
| Cash from Investing | -72.22M | -84.18M | 11.89M | 8.18M | 104.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 87.61M | 54.00K | 100.08M | 100.10M | 100.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.74M | -879.00K | -5.70M | -5.70M | -5.70M |
| Cash from Financing | 81.87M | -825.00K | 94.38M | 94.40M | 94.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.70M | -192.78M | 8.83M | 7.33M | 103.73M |